These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 33713810)

  • 1. Photocoagulation for retinal vein occlusion.
    Hayreh SS
    Prog Retin Eye Res; 2021 Nov; 85():100964. PubMed ID: 33713810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion.
    Hayreh SS; Rojas P; Podhajsky P; Montague P; Woolson RF
    Ophthalmology; 1983 May; 90(5):488-506. PubMed ID: 6192376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of visual prognosis and correlative factors in retinal vein occlusion].
    Zhang H; Xia Y
    Zhonghua Yan Ke Za Zhi; 2002 Feb; 38(2):98-102. PubMed ID: 11955310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ischemia and laser photocoagulation in retinal vein occlusion].
    Rehak M; Storch MW; Hattenbach LO; Feltgen N
    Ophthalmologie; 2022 Nov; 119(11):1121-1128. PubMed ID: 36357589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroids and macular edema from retinal vein occlusion.
    Glacet-Bernard A; Coscas G; Zourdani A; Soubrane G; Souied EH
    Eur J Ophthalmol; 2011; 21 Suppl 6():S37-44. PubMed ID: 23264327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aqueous semaphorin 3A level correlates with retinal macular oedema and ganglion cell degeneration in patients with retinal vein occlusion.
    Guo S; Ren J; Li Z; Fan X; Qin L; Li J
    Acta Ophthalmol; 2019 May; 97(3):273-278. PubMed ID: 30803163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.
    Scott IU; VanVeldhuisen PC; Oden NL; Ip MS; Blodi BA; Hartnett ME; Cohen G;
    Ophthalmology; 2011 Feb; 118(2):345-52. PubMed ID: 20926135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between anti-VEGF therapy and corticosteroid or laser therapy for macular oedema secondary to retinal vein occlusion: A meta-analysis.
    Qian T; Zhao M; Xu X
    J Clin Pharm Ther; 2017 Oct; 42(5):519-529. PubMed ID: 28639290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update in the Management of Macular Edema Following Retinal Vein Occlusions.
    Thorell MR; Goldhardt R
    Curr Ophthalmol Rep; 2016 Mar; 4(1):38-47. PubMed ID: 30345164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of macular edema secondary to central retinal vein occlusion: an evidence-based.
    Aref AA; Scott IU
    Adv Ther; 2011 Jan; 28(1):40-50. PubMed ID: 21153510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study.
    Hayreh SS; Klugman MR; Podhajsky P; Servais GE; Perkins ES
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(4):281-96. PubMed ID: 1698170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalent misconceptions about acute retinal vascular occlusive disorders.
    Hayreh SS
    Prog Retin Eye Res; 2005 Jul; 24(4):493-519. PubMed ID: 15845346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion.
    Chan CK; Ip MS; Vanveldhuisen PC; Oden NL; Scott IU; Tolentino MJ; Blodi BA;
    Ophthalmology; 2011 Jul; 118(7):1364-72. PubMed ID: 21440942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of macular edema secondary to branch retinal vein occlusion: an evidence-based update.
    Aref AA; Scott IU
    Adv Ther; 2011 Jan; 28(1):28-39. PubMed ID: 21153509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term real-world outcomes in retinal vein occlusions: How close are we to the trials?
    Shah PN; Shanmugam MP; Vora UB; Agrawal S; Sirivella I; Suryakanth S; Jayasingh R
    Indian J Ophthalmol; 2022 Dec; 70(12):4370-4375. PubMed ID: 36453347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of antivascular endothelial growth factor therapy on the development of neovascular glaucoma after central retinal vein occlusion: a retrospective analysis.
    Ryu CL; Elfersy A; Desai U; Hessburg T; Edwards P; Gao H
    J Ophthalmol; 2014; 2014():317694. PubMed ID: 24800060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review.
    Glanville J; Patterson J; McCool R; Ferreira A; Gairy K; Pearce I
    BMC Ophthalmol; 2014 Jan; 14():7. PubMed ID: 24447389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, anatomical, and electrophysiological assessments of the central retina following intravitreal bevacizumab for macular edema secondary to retinal vein occlusion.
    Loukianou E; Brouzas D; Chatzistefanou K; Koutsandrea C
    Int Ophthalmol; 2016 Feb; 36(1):21-36. PubMed ID: 25820576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal vein thrombosis: pathogenesis and management.
    Rehak M; Wiedemann P
    J Thromb Haemost; 2010 Sep; 8(9):1886-94. PubMed ID: 20492457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of anti-VEGF therapy on present day management of macular edema due to BRVO and CRVO: a longitudinal analysis on visual function, injection time interval and complications.
    Papadia M; Misteli M; Jeannin B; Herbort CP
    Int Ophthalmol; 2014 Dec; 34(6):1193-201. PubMed ID: 25245600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.